Colossal's artificial egg and Musk's OpenAI lawsuit loss
Biotech claims first fully artificial egg; court rules against Musk in OpenAI case.
Colossal Biosciences, the biotech company focused on de-extinction, announced it has grown baby chicks inside transparent 3D-printed plastic cups at its Dallas headquarters. The company describes this as a 'fully artificial egg,' a breakthrough intended to help revive extinct avian species such as the dodo and the giant moa. However, some scientists are skeptical, arguing that Colossal may be overstating the achievement. The technology could represent an early step toward artificial wombs, sparking both excitement and controversy in the scientific community.
In a separate major development, Elon Musk lost his landmark lawsuit against OpenAI, which centered on allegations that cofounders Sam Altman and Greg Brockman misled him about the company's nonprofit mission. The court decision, covered by MIT Technology Review's AI reporter and attorney Michelle Kim, has significant implications for the ongoing AI race and the governance of AI companies. The ruling underscores the legal complexities surrounding AI development and the challenges of enforcing nonprofit commitments in a rapidly evolving industry.
- Colossal Biosciences grew chickens in 3D-printed artificial eggshells as part of de-extinction efforts for birds like the dodo.
- Some scientists question the breakthrough, but it may advance artificial womb technology.
- Elon Musk lost his lawsuit against OpenAI, alleging Sam Altman misled him about the company's nonprofit mission.
Why It Matters
Advances in artificial wombs and AI governance rulings will shape biotech and AI regulation.